Evaluation of Plasma Amyloid Peptides Aβ(1-40) and Aβ(1-42) as Diagnostic Biomarker of Alzheimer's Disease, its Association with Different Grades of Clinical Severity and 18F-Fluorodeoxyglucose Positron Emission Tomography Z score in the Indian Population: A Case-Control Study

BACKGROUND: We estimated plasma amyloid-peptides levels (Aβ(1-42) and Aβ(1-40)) as diagnostic biomarker of Alzheimer's disease (AD) and evaluated its association with clinical severity and 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) Z score of the different brain regions i...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Hariom, Goyal, Manoj Kumar, Sarma, Phulen, Singh, Harmandeep, Modi, Manish, Sharma, Anchal, Mohanty, Manju, Vishnu, Venugopalan Y., Kumar, Ashok, Mittal, Bhagwant Rai, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771055/
https://www.ncbi.nlm.nih.gov/pubmed/35125757
http://dx.doi.org/10.4103/ijnm.ijnm_50_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771055/
https://www.ncbi.nlm.nih.gov/pubmed/35125757
http://dx.doi.org/10.4103/ijnm.ijnm_50_21

Ejemplares similares